| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 09/19/2007 | EP1833504A2 Sustained delivery of pdgf using self-assembling peptide nanofibers |
| 09/19/2007 | EP1833503A2 Pulmonary surfactant formulations |
| 09/19/2007 | EP1833502A1 Pharmaceutical composition for the treatment of invasive pulmonary aspergillosis |
| 09/19/2007 | EP1833501A1 Laminin receptor binding molecule |
| 09/19/2007 | EP1833500A1 Method to enhance the bone formation activity of bmp by runx2 acetylation |
| 09/19/2007 | EP1833495A1 Dermatologic use of milk proteins |
| 09/19/2007 | EP1833470A2 Nanoparticles for protein drug delivery |
| 09/19/2007 | EP1833306A1 Method of producing a palatability enhancer that can add health value to foodstuffs |
| 09/19/2007 | EP1670923A4 Method for mass production of human follicle stimulating hormone |
| 09/19/2007 | EP1572066A4 Novel method and composition for inhibition of angiogenesis and tumor growth using compounds based on a sequence within mmp-2 |
| 09/19/2007 | EP1471974B1 Tumor necrosis factor combined with interferon in demyelinating diseases |
| 09/19/2007 | EP1467747B1 Use of dimer-specific nuclear localisation signal peptides (dsnls) derived from the stat dna binding domain |
| 09/19/2007 | EP1407044B1 Rna interference mediating small rna molecules |
| 09/19/2007 | EP1345593B1 Lipid microparticles by cryogenic micronization |
| 09/19/2007 | EP1337648B1 Novel cyclodextrin glucanotransferase (cgtase), obtained from i bacillus agaradherens /i (dsm 9948) and detergents and cleaning agents containing said novel cyclodextrin glucanotransferase |
| 09/19/2007 | EP1326990B1 Packaging of positive-strand rna virus replicon particles |
| 09/19/2007 | EP1317553B1 Pde8a and uses thereof |
| 09/19/2007 | EP1255844B1 Humanized anti-ccr2 antibodies and methods of use therefor |
| 09/19/2007 | EP1242110B1 Composition for treating prostate cancer |
| 09/19/2007 | EP1190071B1 17867, a novel human aminopeptidase |
| 09/19/2007 | EP1151009B1 Antimicrobial/endotoxin neutralizing polypeptide |
| 09/19/2007 | EP1020522B1 Natural human antibody |
| 09/19/2007 | EP0714438B1 A novel homeobox factor which stimulates insulin expression in pancreatic islet cells |
| 09/19/2007 | CN101039957A Synthetic chemokine receptor ligands and methods of use thereof |
| 09/19/2007 | CN101039954A Solid phase peptide sythesis |
| 09/19/2007 | CN101039953A Therapeutic and diagnostic agents |
| 09/19/2007 | CN101039690A Enzyme inhibitors and uses thereof |
| 09/19/2007 | CN101039689A Topical compositions and methods for epithelial-related conditions |
| 09/19/2007 | CN101039684A Methods to enhance hemodynamic stability using oxygen carrying compositions |
| 09/19/2007 | CN101039660A Stable pegylated interferon formulation |
| 09/19/2007 | CN101037691A CENP-E combined protein and encoding gene and application |
| 09/19/2007 | CN101037678A Preparation of decorative yak blood source SOD and decorative yak blood source SOD anticancer health food by yak blood |
| 09/19/2007 | CN101037478A Rebuild golden staphylococcus enterotoxin N and preparation and application thereof |
| 09/19/2007 | CN101037476A Fusion protein for preparing hepatitis B vaccine and its carrier |
| 09/19/2007 | CN101037473A R. grahami rnmunoregulating polypeptide, gene and variant and its application in medicine production |
| 09/19/2007 | CN101037472A LHRH antagonist with low-histamine releasing function |
| 09/19/2007 | CN101037471A Half electric charge matching nonapeptide and application thereof |
| 09/19/2007 | CN101036786A Immunomodulation agent with adjuvant having function for treating atherosclerosis |
| 09/19/2007 | CN101036782A The application and preparation of anti-inflammatory fused protein for restraining tumor necrosis factor |
| 09/19/2007 | CN101036781A Function of Renyuan hepatic stellate cells for treating liver diseases by activating the corresponding protein |
| 09/19/2007 | CN101036780A Application of self-assembled short peptide in the medicine for treating burn and face wound |
| 09/19/2007 | CN101036730A Selenium germanium peptide jujube tea powder for curing cancer radically |
| 09/19/2007 | CN101036729A Biological selenium germanium peptide maggot jujube tea powder for preventing SARS |
| 09/19/2007 | CN100338219C Tissue specific expression of retinoblastoma protein |
| 09/19/2007 | CN100338217C Single chain recombinant t cell receptors |
| 09/19/2007 | CN100338212C Microencapsulated cell of human tissue kallikrein, microencapsulating method and application thereof |
| 09/19/2007 | CN100338093C Flexible container system for storage of stabilized hemoglobin solutions |
| 09/19/2007 | CN100338044C HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis |
| 09/19/2007 | CN100337685C Medicinal preparation for reducing hair growth, hair follicle and hair shaft dimension and hair pigmentation |
| 09/19/2007 | CN100337684C Thymic pentapeptide aqua prepn and its prepn process and application |
| 09/19/2007 | CN100337604C Device for mixing and/or injection cement |
| 09/18/2007 | USRE39847 Method of treating a systemic disease |
| 09/18/2007 | US7271311 Mammalian model for diabetes |
| 09/18/2007 | US7271255 Pichia methanolica secretory signal |
| 09/18/2007 | US7271248 Polypeptide for therapy of viral infections, cancer, septic shock |
| 09/18/2007 | US7271247 Antibody that binds to the protein; given amino acid sequence |
| 09/18/2007 | US7271242 Cytotoxic cyplasin of the sea hare, aplysia punctata, cdna cloning and expression of bioreactive recombinants |
| 09/18/2007 | US7271241 Directed evolution methods for improving polypeptide folding and solubility and superfolder fluorescent proteins generated thereby |
| 09/18/2007 | US7271240 Protein for use as diagnostic and therapeutic tool in cancer treatment |
| 09/18/2007 | US7271239 D-isomers of antimicrobial peptide |
| 09/18/2007 | US7271238 Amylin agonist peptides and uses therefor |
| 09/18/2007 | US7271156 Immunostimulatory nucleic acids |
| 09/18/2007 | US7271152 Treating thrombosis by administering a CD154 inhibitor, such as a metalloproteinase inhibitor |
| 09/18/2007 | US7271151 administering to effect phosphate metabolism in a patient; Metastatic-tumor Excreted Phosphaturic-Element (MERE) or "phosphatonin"; treating X-linked rickets and tumour osteomalacia for example |
| 09/18/2007 | US7271150 Modified growth hormone |
| 09/18/2007 | US7271149 Comprises chimeric glucagon-like peptides-1 (GLP-1) for treating obesity and non-insulin dependent diabetes mellitus |
| 09/18/2007 | US7271148 Inhibition of cellular proteases |
| 09/18/2007 | US7271147 Tripropeptin antibiotic |
| 09/18/2007 | US7271146 Methods for treatment of Helicobacter pylori-associated disorders |
| 09/18/2007 | US7271145 Artificial blood; mixture of surface treated hemoglobin in aqueous diluent |
| 09/18/2007 | US7271144 Therapeutic fibrin-derived peptides and uses thereof |
| 09/18/2007 | US7271143 Peptides for regulation of urokinase (uPA) and tissue type (tPA) plasminogen activator and method of optimizing therapeutic efficacy |
| 09/18/2007 | US7270994 carrier can be skimmed milk; inventor selected the microbial populations in pickle and salt-preserving clover (Chinese traditional food) as target and applied high cholesterol culture medium |
| 09/18/2007 | US7270980 Diagnosing prostate cancer in humans; obtain sample, incubate with preferential binding agent, detect bound protein, bound protein indicates prostate cancer |
| 09/18/2007 | US7270975 Methods for regulating bud-hypha transitions and cAMP levels in Candida albicans |
| 09/18/2007 | US7270973 by passivation and adsorption; hydrolase enzyme immobilized within polyelectrolyte multilayers and a polymerizable end-capping layer; storage stable; |
| 09/18/2007 | US7270972 Process for producing subunit peptide originating in polymer protein |
| 09/18/2007 | US7270966 for drug screening agents for treatment and/or prevention of cystic fibrosis by receptor binding ligand; genetic engineering |
| 09/18/2007 | US7270963 Growth differentiation factor, lefty-2 |
| 09/18/2007 | US7270962 Screening for agonist or antagonist to axon outgrowth inhibitors for use in prevention and designing treatments for brain, stroke and spinal injured individuals |
| 09/18/2007 | US7270960 Diagnosis of ovarian carcinomas |
| 09/18/2007 | US7270832 Carriers for administration of active principles such as drugs or nutriments, cosmetic products or plant health products such as herbicides, pesticides, insecticides, fungicides, etc. |
| 09/18/2007 | US7270827 For prophylaxis and therapy of microbial infection and eliciting a protective immune response |
| 09/18/2007 | US7270826 Methods of using Botulinum toxin for the treatment of hypervolemic lip deformity (lip ectropion) |
| 09/18/2007 | US7270825 Production of a parvovirus vaccine in plants as viral coat protein fusions |
| 09/18/2007 | US7270824 Seaweed extract from red macroalgae obtained through solvent extraction; skin and phanera care |
| 09/18/2007 | US7270822 Active complex of alpha-lactalbumin (hamlet) and cofactor |
| 09/18/2007 | US7270821 Hepatitis B core antigen fusion proteins |
| 09/18/2007 | US7270819 Isolated nucleic acid molecules encoding isolated peptides which correspond to contiguous amino acids of an SSX molecule or NY-ESO-1 and uses thereof |
| 09/18/2007 | US7270817 ACPL antibodies and methods of use thereof |
| 09/18/2007 | US7270816 Interleukins; fusion proteins; solid phase synthesis; kits |
| 09/18/2007 | US7270815 2-O sulfatase compositions and related methods |
| 09/18/2007 | US7270814 Using carbohydrate oxidase as deodorizing compound |
| 09/18/2007 | US7270809 cysteine-added granulocyte colony-stimulating factor; prolongs circulating half-lives of protein therapeutics so proteins do not have to be injected frequently; adding cysteine residues to non-essential regions using site-directed mutagenesis; covalently coupling a cysteine-reactive polymer via cysteine |
| 09/18/2007 | US7270807 subtilisin, pepsin or trypsin used for the protein hydrolysis of ground oyster flesh; liquid form; freeze dried powder form |
| 09/18/2007 | US7270287 Botulinum toxin treatment for kinesia |
| 09/18/2007 | CA2426543C Anti-angiogenic polypeptides |
| 09/18/2007 | CA2392473C Bioadhesive drug delivery system |
| 09/18/2007 | CA2315228C Layered rate controlling membranes for use in an electrotransport device |
| 09/18/2007 | CA2304662C Methods for fabricating polymer-based controlled release preparations |